Overall rank by patents
#2,330
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
USPTO PatentsView assignee record — 168 granted patents across 53 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
168
Total patents granted
53
CPC technology areas
9.3
Avg claims per patent
-59%
5-year filing velocity
The verdict
KOREA holds 168 US patents across 53 technology areas — rank #2,330 of 50,000 tracked assignees.
- #2,330
- of 50,000 US assignees by volume
- Top 12%
- by Innovation Score (50.8/100)
- 9.3
- avg claims per patent
- -59%
- filing velocity, last 5 yrs
Portfolio overview
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY has been granted 168 US utility patents between 2015 and 2025, placing KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY at rank #2,330 across all assignees tracked by PlainPatent. This portfolio spans 53 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 50.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 49 grants, compared with 119 in the 2015–2019 window — a -59% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's 9.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 53 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY against peers pursuing similar technology classes.
How does KOREA compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Korea Research In… ◀ 168
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
168 patents
What this shows KOREA holds 168 patents — placing it at rank #2,330 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
KOREA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 29 | 17.3% |
| 2016 | 26 | 15.5% |
| 2017 | 26 | 15.5% |
| 2018 | 21 | 12.5% |
| 2019 | 17 | 10.1% |
| 2020 | 13 | 7.7% |
| 2021 | 8 | 4.8% |
| 2022 | 4 | 2.4% |
| 2023 | 5 | 3.0% |
| 2024 | 5 | 3.0% |
| 2025 | 14 | 8.3% |
Which technologies does KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY patent most?
Top 15 of 53 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY hold?
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY holds 168 US granted patents filed between 2015 and 2025, spanning 53 technology areas.
What is KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's Innovation Score?
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY has an Innovation Score of 50.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY focus on?
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 92 patents. The company has filed patents in 53 CPC subclasses total.
Is KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's patent filing rate increasing or decreasing?
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's recent filing velocity is -59% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's patents?
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's patents average 9.3 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61K technology
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
